Age-Related Adaptive Immune Changes in Parkinson's Disease
- PMID: 35661020
- PMCID: PMC9535571
- DOI: 10.3233/JPD-223228
Age-Related Adaptive Immune Changes in Parkinson's Disease
Abstract
Ageing is a major risk factor for most neurodegenerative diseases, including Parkinson's disease (PD). Progressive age-related dysregulation of the immune system is termed immunosenescence and is responsible for the weakened response to novel antigens, increased susceptibility to infections and reduced effectiveness of vaccines seen in the elderly. Immune activation, both within the brain and periphery, is heavily implicated in PD but the role of immunosenescence has not been fully explored. Studies to date provide some evidence for an attenuation in immunosenescence in PD, particularly a reduction in senescent CD8 T lymphocytes in PD cases compared to similarly aged controls. Here, we discuss recent evidence of age-related immune abnormalities in PD with a focus on T cell senescence and explore their potential role in disease pathogenesis and development.
Keywords: Parkinson’s disease; T lymphocytes; ageing; immunosenescence.
Conflict of interest statement
The authors have no conflict of interest to report.
Figures

References
-
- Fajemiroye JO, Cunha da LC, Saavedra-Rodríguez R, Rodrigues KL, Naves LM, Mourão AA, Silva da EF, Williams NEE, Martins JLR, Sousa RB, Rebelo ACS, Reis da AA S, Santos da R S, Ferreira-Neto ML, Pedrino GR (2018) Aging-induced biological changes and cardiovascular diseases. Biomed Res Int 2018, e7156435. - PMC - PubMed
-
- Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, Bohr VA (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15, 565–581. - PubMed
-
- Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 24, 1159–1169. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials